Ismayilov, R. Et Al. 2022. Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma. Eurasian Journal of Medicine , vol.54, no.1 , 70-72.

Ismayilov, R., AKTEPE, O. H., Sardarova, K., Leblebici, C. B., & ERMAN, M., (2022). Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma. Eurasian Journal of Medicine , vol.54, no.1, 70-72.

Ismayilov, Rashad Et Al. "Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma," Eurasian Journal of Medicine , vol.54, no.1, 70-72, 2022

Ismayilov, Rashad Et Al. "Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma." Eurasian Journal of Medicine , vol.54, no.1, pp.70-72, 2022

Ismayilov, R. Et Al. (2022) . "Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma." Eurasian Journal of Medicine , vol.54, no.1, pp.70-72.

@article{article, author={Rashad Ismayilov Et Al. }, title={Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma}, journal={Eurasian Journal of Medicine}, year=2022, pages={70-72} }